Projects
Translational and Transdisciplinary research in Modeling Infectious Diseases (TransMID). University of Antwerp
Multidisciplinary research on vaccination and infectious diseases (Vaxinfectio-PO). University of Antwerp
Infectious diseases and environmental health University of Antwerp
Multidisciplinary research on vaccination and infectious diseases. University of Antwerp
ASCID: Antwerp Study Centre for Infectious Diseases. University of Antwerp
Optimized detection of infectious diseases of the oral cavity by NA based assays using an improved, safe and user-friendly mouthwash.d.m University of Antwerp
Novel molecular intervention technology for infectious and allergic respiratory diseases Ghent University
This collaborative interfaculty project aims at the development of novel
therapeutic approaches for the treatment of infectious and allergic
respiratory diseases and the elucidation of the underlying mechanisms. Animal
models of Mycobacterium tuberculosis and Influenza infection along with models
for mild to severe asthma will be combined with modified vaccinogens, immune
interference and ...
Novel molecular intervention technology for infectious and allergic respiratory diseases Ghent University
This collaborative interfaculty project aims at the development of novel
therapeutic approaches for the treatment of infectious and allergic
respiratory diseases and the elucidation of the underlying mechanisms. Animal
models of Mycobacterium tuberculosis and Influenza infection along with models
for mild to severe asthma will be combined with modified vaccinogens, immune
interference and ...
Hybrid CAR – improving cellular therapies for infectious diseases Ghent University
In this project we aim to develop a Chimeric Antigen Receptor (CAR) T cell-based therapy against a viral infection, where virus becomes effectively eliminated from the patient’s organism. CAR T cell therapy has been successfully applied to treatment of haematological malignancies, but its usage to treat viral infections so far has failed clinical trials. The novelty of our approach consists in targeting not only infected host’s cells ...